FibroGen has licensed an experimental cancer drug from biotechnology startup Fortis Therapeutics and grabbed an option to acquire the smaller company at a later date.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,